Pictet Asset Management (Switzerland)’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $135K | Sell |
10,855
-3,746
| -26% | -$46.6K | ﹤0.01% | 1807 |
|
|
2023
Q1 | $205K | Hold |
14,601
| – | – | ﹤0.01% | 1717 |
|
|
2022
Q4 | $209K | Buy |
+14,601
| New | +$209K | ﹤0.01% | 1710 |
|
|
2022
Q3 | – | Sell |
-149,696
| Closed | -$4.25M | – | 1590 |
|
|
2022
Q2 | $4.25M | Buy |
149,696
+142,192
| +1,895% | +$4.04M | 0.01% | 786 |
|
|
2022
Q1 | $265K | Hold |
7,504
| – | – | ﹤0.01% | 1422 |
|
|
2021
Q4 | $314K | Hold |
7,504
| – | – | ﹤0.01% | 1369 |
|
|
2021
Q3 | $368K | Buy |
+7,504
| New | +$368K | ﹤0.01% | 1316 |
|